On 2023-05-10, HTG Molecular Diagnostics, Inc. (HTGMQ) announced earnings per share of $-2.28 for the fiscal quarter ending 2023-03-31, missing the average analyst estimate of $-1.94.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2023-05-10 | 2023-03-31 | $-1.94 | $-2.28 |
| 2022-11-10 | 2022-09-30 | $-6.24 | $-4.92 |
| 2022-08-11 | 2022-06-30 | $-6.96 | $-6.48 |
| 2022-05-12 | 2022-03-31 | $-8.52 | $-9.72 |
| 2022-03-29 | 2021-12-31 | $-7.44 | $-8.28 |
| 2021-11-10 | 2021-09-30 | $-7.20 | $-7.20 |
| 2021-08-12 | 2021-06-30 | $-9.48 | $-7.20 |
| 2021-05-13 | 2021-03-31 | $-11.40 | $-9.60 |
| 2020-11-10 | 2020-09-30 | $-12.60 | $-12.60 |
| 2020-08-11 | 2020-06-30 | $-14.40 | $-14.40 |
| 2020-05-13 | 2020-03-31 | $-14.40 | $-14.40 |
| 2020-03-25 | 2019-12-31 | $-14.40 | $-1.80 |
| 2019-11-12 | 2019-09-30 | $-25.20 | $-27.00 |
| 2019-08-06 | 2019-06-30 | $-27.00 | $-30.60 |
| 2019-05-09 | 2019-03-31 | $-30.60 | $-34.20 |
| 2019-03-07 | 2018-12-31 | $-36.00 | $-12.60 |
| 2018-11-08 | 2018-09-30 | $-34.20 | $-30.60 |
| 2018-08-07 | 2018-06-30 | $-34.20 | $-25.20 |
| 2018-05-10 | 2018-03-31 | $-39.60 | $-39.60 |
| 2018-03-22 | 2017-12-31 | $-41.40 | $-27.00 |
| 2017-11-07 | 2017-09-30 | $-88.19 | $-82.79 |
| 2017-08-08 | 2017-06-30 | $-107.99 | $-107.99 |
| 2017-05-15 | 2017-03-31 | $-104.39 | $-131.39 |
| 2017-03-23 | 2016-12-31 | $-142.19 | $-136.79 |
| 2016-11-14 | 2016-09-30 | $-156.58 | $-165.58 |
| 2016-08-09 | 2016-06-30 | -- | $-176.38 |
| 2016-05-12 | 2016-03-31 | $-149.39 | $-183.58 |
| 2016-03-24 | 2015-12-31 | $-142.19 | $-149.39 |
| 2015-11-12 | 2015-09-30 | $-136.79 | $-136.79 |
| 2015-08-06 | 2015-06-30 | $-183.58 | $-311.37 |
| 2015-06-01 | 2015-03-31 | -- | $-2697.93 |